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ABSTRACT 
 
A liposome is an artificially-prepared vesicle composed of a lipid bilayer. This project aims 
to produce liposomes using human adipose tissue derived lipids (ATDL). Furthermore, the 
study attempts to find the alternative use of discarded human adipose tissue after the 
liposuction operation. Conventionally prepared liposomes are usually made up of 
phosphatidylcholine and cholesterol, two major constituents of cell membrane. The presence 
of other phospholipids like phosphatidylserine, phosphatidylinositol, 
phosphatidylethonolamine and sphingophospholipids of the cells and organelles membranes 
may mimic the natural cell membrane and stabilise the liposomes further and increase its 
efficiency as intracellular drug delivery vehicle. These other useful phospholipids could be 
extracted from the discarded adipose tissues.  
The lipids were separated from the human adipose tissue by Folch Method (Folch et al., 
1957) and characterised using FTIR. Thin film hydration method was adapted to produce 
liposomes with 2 different sources, lecithin- cholesterol and ATDL. The liposomes were 
analysed under light microscope and characterised using DLS. Then these liposomes were 
loaded with trehalose, a known disaccharide and cryoprotectant. Moreover, the drug 
encapsulation efficiency and effect of trehalose loaded liposomes on the cryopreservation of 
red blood cells were compared between conventional and the proposed method. The 
liposomes made up of ATDL are smaller in size and have less encapsulation efficiency as 
compared to conventional liposomes. The conventionally produced liposomes loaded with 
trehalose have very high cryoprotective properties (Viability-85% RBCs) but at the same 
time the cryoprotective properties of ATDL liposomes loaded with trehalose is also quite 
significant (viability-70% RBCs).The lower cryoprotective ability of the ATDL liposomes 
may be due to the lower encapsulation efficiency of it for the water soluble drugs such as 
trehalose. 
 
 
  
CHAPTER 1: INTRODUCTION 
 
1.1- Liposome production , application and advantages 
Liposomes are microscopic vesicles that consist of an aqueous centre with a phospholipid 
bilayer. Liposomes were first described in 1961 as a model of cellular membranes. They were 
discovered in 1961 by Alec D. Bangham who was at that point studying phospholipids and 
blood clotting, and since then liposomes became very versatile tools in biology, biochemistry 
and medicinal biology. Bangham discovered that phospholipid combined with water 
immediately forms a bi-layered sphere because one end of each molecule is water soluble or 
hydrophilic, while the opposite end is water insoluble or hydrophobic. 
1.1.1 History: 
The history of liposomes is usually divided into three periods: genesis, middle age and 
modern era. 
a) Genesis (1968-75) 
Liposome’s physiochemical characterisation was done in this period and thin lipid film 
hydration method was also developed which could prepare multilamellar vesicles 
(MLVs).The resemblance of liposomes to biological membrane has made it a subject for 
study of the nature of biological membranes. 
b) Middle age (1975-85) 
Basic research increased the understanding of liposome stability and interaction mechanism 
within the system thus increasing their utility. This period also saw the rise of various other 
liposome preparation techniques. Also, the phsio-chemical characteristics of the liposomes 
were vastly known in this period thus improving their performance as drug carrier systems. 
c) Modern era (1985 onwards) 
Today, liposomes are used successfully in various disciplines such as biology, chemical 
science even mathematics and physics. The first liposomal pharmaceutical product received 
FDA approval in the mid-1990 was Ambisome, a parenteral amphotericin- B based liposomal 
product. Currently there are at least 8 liposomal pharmaceutical products currently marketed 
with many more in various stages of clinical trials. The widespread liposome research is 
promising many more products in the near future. 
1.1.2 Types of Liposomes: 
Vesicle type Abbreviation Diameter size No. of lipid bilayer 
Unilamellar vesicle 
Small Unilamellar 
vesicle  
Medium Unilamellar 
vesicle 
UV 
SUV 
 
MUV 
All size range 
20-100nm 
 
More than 100nm 
One 
One 
 
One 
Large Unilamellar 
vesicle 
LUV More than 100nm One 
Giant Unilamellar 
vesicle  
GUV More than 1 micro 
meter 
One 
Oligolamellar vesicle  OLV 0.1-1 micro meter Approx 5 
Multilamellar vesicle 
Multivesicular 
vesicle  
MLV 
MV 
More than 0.5 
More than 1 micro 
meter 
5-25 
Multi compartmental 
structure 
 
Table 1: Type of liposomes based on size (Abdus Samad et. al., 2007) 
1.1.3 Liposome Preparation methods: 
Liposomes are prepared by various methods: 
1. Passive loading- In this method the encapsulated drug or other substances is loaded before 
or during the formation of the vesicle 
 Mechanical dispersion method 
o Lipid film hydration by hand shaking non hand shaking or freeze drying 
o Micro emulsification 
o Sonication 
o French pressure cell 
o Membrane extrusion 
o Dried constituted vesicles 
o Freeze thawed liposomes 
 Solvent evaporation method 
o Ethanol injection 
o Ether injection 
o Double emulsion vesicles 
o Reverse phase evaporation vesicles 
o Stable plurilamellar vesicles 
 Detergent removal methods 
o Detergent (cholate, alkylglycoside, trito n X-100) removal from mixed 
micelles 
o Dialysis 
o Column chromatography 
o Dilution 
o Reconstituted sandal virus enveloped vesicles 
2. Active loading- in this method encapsulated drugs or other substances are loaded after the 
vesicle is formed. 
1.1.4 Properties of Liposomes: 
The size, the lamellarity (Unilamellar or Multilamellar) and lipid composition of the bilayers 
influence many of their important properties like the fluidity, permeability, stability and 
structure; these can be controlled and customized to serve specific needs. These properties are 
also influenced by external parameters like temperature, ionic strength and the presence of 
certain molecules nearby. The liposome surface can also be modified to achieve various 
goals: 
 Attachment of hydrophobic polymers can result in long circulating liposomes. 
 Attachment of label allows the monitoring of the fate of liposomes in a body or cell. 
 Entrapment of positively charged ions allows DNA binding and efficient cell 
transfection 
 Attachment of either antigen or antibody leads to the formation of liposome-based 
immunoassay system 
 
The properties that make them useful for different applications are: 
 Surfactant property 
 Structural stability on dilution of the liposomes 
 Varying permeability of the bilayer when exposed to different molecules. 
 Ability to entrap both water soluble (hydrophilic) and insoluble 
(hydrophobic) substances and deliver them into desired targets. 
 
1.1.5 Applications of Liposomes: 
Application of liposomes are in various fields such as drug delivery,  topical drug 
encapsulation, treatment of human immunodeficiency virus infections, enhanced 
antimicrobial efficacy, lipotransfection ,liposome vaccines. Liposome can administered orally 
or there are liposome aerosols present these days, topical application as well lymphatic 
targeting with liposomes is also possible. Liposomes are also being used in nucleic acid 
therapy, in eye disorders, as vaccine adjuvant, for brain targeting and many other 
applications. 
Applications of liposomes can be divided into two categories: therapeutic and diagnostic 
depending upon the constituents of liposomes drugs or various markers. The beneﬁts and 
limitations of liposome loaded with drug critically depend on the interaction of liposomes 
with cells in vivo after their administration. 
 In vitro and in vivo studies of interactions of liposomes with cells have shown that the 
interaction is either simple adsorption or endocytosis. Fusion of liposomes with cell 
membranes is very rare. The fourth possible interaction is exchange of bilayer constituents 
with components of cell membranes. 
Liposomes provide several advantages in delivering genes to cells. (a) Liposomes can 
combine with negatively and positively charged molecules equally. (b) Liposomes offer 
protection to the encapsulated DNA from harmful processes and environment. (c) Liposomes 
can carry large pieces of DNA, pieces as large as a chromosome. (d) Liposomes can be 
targeted to specific cells or tissues. The ability to chemically synthesize a wide variety of 
liposomes has resulted in a highly adaptable and flexible system capable of gene delivery 
both in vitro and in vivo. 
Cationic liposomes are positively charged liposomes, which interact (bind) with the 
negatively charged DNA to form a stable complex. Cationic liposomes have a positively 
charged lipid and a co-lipid. Co-lipids, which are the helper lipids, are required for 
stabilization of liposome complex. A variety of cationic liposomes are commercially 
available and many others are under development. One of the most frequently used positive 
charged lipids is lipofectin. PH-sensitive, or negatively-charged liposomes, enclose DNA 
rather than complexing with it. Since both the DNA and the lipid are negatively charged, 
repulsion rather than complex formation occurs. Yet, some DNA does manage to get 
entrapped within the aqueous interior of these negatively charged liposomes. To date, 
cationic liposomes have been much more efficient at gene delivery both than pH-sensitive 
liposomes.PH-sensitive liposomes have the potential to be much more efficient at in 
vivo DNA delivery than their cationic counterparts. 
1.1.6 Marketed Liposomal Products: 
Various marketed formulations of liposomes are: 
Product  Drug  Company  Use 
1.Myocet  Liposomal 
doxorubicin 
Cephalon (UK) Limited 
and Triveni  interchem 
private limited 
 
Combinational 
therapy for treatment 
of recurrent breast 
cancer 
2.Doxil, Caelyx Liposomal 
doxorubicin 
Sequus 
Pharmaceuticals,Inc.,C.A. 
treatment of 
refractory Kaposi's 
sarcoma, recurrent 
breast cancer and 
ovarian cancer 
 
3.LipoDox Liposomal 
doxorubicin 
Sun Pharma Global and  
Oddway international 
 
treatment of 
refractory Kaposi's 
sarcoma, recurrent 
breast cancer and 
ovarian cancer 
 
4.Thermodox Liposomal 
doxorubicin 
Celsion corporation 
 
treatment of  liver 
cancer  and also 
recurrent chest wall 
breast cancer 
5.DaunoXome Liposomal 
Daunorubicin 
NeXstar 
Pharmaceuticals,Inc.,CO 
treatment of  
Kaposi's sarcoma 
6.Ambisome  Liposomal 
Amphoteracin B 
NeXstar 
Pharmaceuticals,Inc.,CO 
treatment of fungal 
infection 
7.Marqibo  Liposomal 
vincristine 
Talon therapeutics  treatment of 
metastatic malignant 
uveal melanoma 
8.Visudyne  Liposomal 
verteporfin 
Novartis Pharmaceuticals 
UK Ltd and 
 
ciba-vision-ophthalmics 
treatment of age-
related macular 
degeneration, 
pathologic myopia 
and ocular 
histoplasmosis. 
 
 
9.DepoCyt Liposomal 
cytarabine 
Enzon Pharmaceuticals, 
Inc, MundiPharma, 
including its independent 
but associated companies, 
in Europe and most other 
countries,  two Pacira 
cGMP manufacturing 
facilities 
Treatment of 
neoplastic 
meningitis and 
lymphomatous 
meningitis.  
 
10. DepoDur Liposomal morphine 
sulphate 
EKR Therapeutics, Flynn 
Pharma(UK), Pacira  
cGMP manufacturing 
facilities 
treatment of 
postoperative pain  
11. Arikace  Liposomal amikacin Insmed Incorporated treatment of lung 
infections due to 
pathogens 
12. Lipoplatin  Liposomal cisplatin Regulon Inc Treatment of lung, 
head and neck, 
ovarian, bladder and 
testicular cancers. 
 
13. LEP-ETU Liposomal 
Paclitaxel 
NeoPharm, Inc It is used for 
treatment of ovarian, 
breast and lung 
cancer. 
14. Epaxal  Hepatitis A vaccine Crucell UK Ltd, Crucell 
Italy S.r.l.,Masta ltd 
It is hepatitis A 
vaccine 
15. Inflexal V  Influenza vaccine Crucell UK Ltd, Crucell 
Italy S.r.l., 
It is influenza 
vaccine 
16. Abelcet  Liposomal 
Amphotericin B 
The liposome company,NJ It is used to treat 
infections caused by 
fungi and yeasts. 
17.Amphocil Liposomal 
Amphotericin B 
Sequus 
pharmaceuticals,Inc,C.A 
It  is used to treat 
serious fungal 
infections, which 
can occur throughout 
the body 
18. MiKasome Liposomal amikacin  NeXstar 
Pharmaceuticals,Inc.,CO 
An agent in clinical 
trials for treating 
complicated UTIs, 
acute infections in 
cystic fibrosis, 
nosocomial 
pneumonia 
19. DC99 Liposomal 
doxorubicin 
Liposome Co.,NJ,USA Used to treat cancer 
20. ELA-Max Liposomal lidocaine Biozone labs,CA,USA Lidocaine is a local 
anesthetic .Lidocaine 
topical is used to 
reduce pain or 
discomfort caused 
by skin irritation 
Table 2: Liposomal formulations already present in market and their applications 
 
1.2 Adipose Tissue  
Adipose tissue is a type of connective tissue that is a major storage site for fat in mammals in 
the form of triglycerides. Adipose tissue in mammals is of two different types: white adipose 
tissue and brown adipose tissue. The amount and distribution of each type of adipose tissue 
vary from species to species. In adult mammals, adipose tissue contains mostly lipid-filled 
cells called adipocytes. In addition to adipocytes, adipose tissue also contains stromal-
vascular cells including fibroblastic connective tissue cells, leukocytes and pre-adipocytes. 
Excess of adipose tissue is the main reason for obesity in mammals; obesity does not depend 
on total body weight it actually depends on total body fat which constitutes mainly of 
adipocytes. 
The lipid droplets in adipose tissue can unioculor or multiocular. Unioculor cells have a large 
single lipid droplet, and the mitochondria are pushed outwards, towards the cell membrane. 
The unioculor cells are mostly 25-200 microns in size. Multiocular cells have many lipid 
droplets, the droplet may be 25 microns and the cell size is about 60 microns. 
About 60-85% the weight of adipose tissue constitute of lipids most of them being (90-99%) 
trigycerides, a trace amounts of phosolipids, cholesterol, digyleceride is also present. This 
lipid mixture contains six fatty acids, namely myristic, palmitoleic, oleic, plamitic, stearic, 
oand linoleic. The rest of the  weight of white adipose tissue is composed of water (5 to 30%) 
and protein (2 to 3%). 
1.2.1 Cell membrane: 
Cell membrane is a biological semi-permeable membrane that separates the cell from the 
outside environment. It is selectively permeable allowing the entry of only some ions and 
molecules. Its main function is to protect cell from foreigners. Cell membrane is made up of 
lipid bilayer and some embedded protein. 
According to fluid mosaic model biological membranes can be considered as a two 
dimensional fluid in which protein and lipid dissolve easily. The lipid bilayer that forms the 
basis of the cell membrane actually forms a 2-D liquid; the cell membrane also contains a lot 
of protein which gives a support structure. 
Lipid bilayer is formed through the process of self-assembly. The cell membrane consists 
mainly of a thin layer of amphipathic phospholipids which spontaneously arrange themselves 
so that the hydrophobic "tail" regions are isolated from the surrounding polar liquids, causing 
the more hydrophilic "head" regions to associate with non-polar regions of the resulting 
bilayer. This forms a continuous spherical lipid bilayer. All kind of forces such as van der 
walls, electrostatic and hydrogen bond play a factor in membrane formation. But the most 
important factor is the hydrophobic interactions. 
Lipid bilayer is generally impenetrable for ions and polar molecules. The arrangement of 
lipid bilayer is such that polar solutes are prevented from entering it, while hydrophobic 
molecules can pass freely. This gives the cell membrane the ability to be selectively 
permeable towards transmembrane protein complexes. 
1.3 RBC Cryopreservation 
 RBCs are biconcave blood cells, which possess hemoglobin (Hb), Membrane contain 
equimolar quantities of phospholipids ,unestrified cholesterol with small amounts of 
glycolipids and free fatty acids,52% of RBC membrane is comprised of membrane proteins, 
these  protein provides the structural support to the membrane. Accidents and certain diseases 
causing anaemia require immediate transfusion of RBC’s. Red blood cells are made in the 
bone marrow. They live for about 120 days in the bloodstream and then die. Lack of RBC’s 
can leads to oxygen depletion in brain and can lead to coma as well as death. Thus it is very 
important to preserve RBC, it can be preserved at 42 degree centigrade for 40 days or else it 
can be cryopreserved with the addition of certain cryoprotectants. 
Cryopreservation is done to preserve cells in low temperature, at such low temperature all 
biological activities are stopped and cells do not die. When the cells are being cryopreserved 
ice is formed which is harmful for the cells. To avoid intra and extracellular ice 
cryoprotectants are added. Cryoprotectants are of two types permeating and non-permeating. 
Once the cells and the cryoprotectants have been combined and dispensed into vials, the next 
step is to cool the suspension. The rate of cooling is important since it affects the rate of 
formation and size of ice crystals, as well as the solution effects that occur during freezing. 
Different types of cells may require different cooling rates; however a uniform cooling rate of 
1°C per minute from ambient temperature is effective for a wide variety of cells. After the 
samples are taken out from liquid nitrogen the cells are thawed. Different thawing protocols 
are used depending upon the type of cell. Generally rapid thawing is best in order to get 
maximum viability of the recovered cells. After thawing the supernatant is removed and the 
cells are resuspended in fresh media to remove residual cryoprotective agent. Post-thaw 
viability tests are used to determine the effectiveness of the procedure. 
 
 
 
 
 
 
 
 
                                                                                                
 
 
 
CHAPTER 2: LITERATURE REVIEW 
 
a) Samad A. et.al, 2007-Liposomal drug delivery systems: an Update review 
Liposomes are small spherical vesciles, which can uptake potent drugs and deliver than at the 
required site for therapeutic benefits. The therapeutic index for drugs are usually small, in 
such cases encasing them a in protective liposome provides better target delivery and 
accumulation at target site. The liposomes are characterized depending on chemical, physical 
and biological parameters. This mode of drug delivery is more effective and safe for 
administration of antiviral, antimicrobial, antifungal drugs. The new developments in this 
field are specific cell binding properties of drug carrying liposome to a target cell. Anticancer 
drugs like doxuribicin, mioxtrone have already been loaded on to sheath liposomes. 
 
b) Mohammad Riaz, 1996-Liposme preparation method 
Liposome vesicles have a central aqueous core which is enclosed by phospholipid bilayers. 
Molecules of low molecular weight to high molecular weight all have been incorporated 
within liposomes. The water soluble components are present in the aqueous core while the 
lipid soluble components get entrapped in the lipid bilayers. Liposome encapsulated drugs 
can be administered by various routes: intravenous, oral, local application, ocular. Liposomes 
are classified based on size, preparation method and type. Liposomes are prepared by several 
methods namely mechanical method, solvent evaporation method and detergent removal 
method. 
 
c) Uhumwangho MU et. al., 2005-Current trends in the production and biomedical 
application of liposomes: a review 
This paper reviews methods for preparation of liposome, their stability, biodistribuation and 
their uses as drug carrier. The conventional method of preparation, prepares mutilamellar 
vesicles but other methods are used to produce small unilamellar vesicle for better tissue 
detection. There are other methods for preparation of large unilamellar vesicle; each method 
has its own advantages and disadvantages. Liposomal encapsulation of drugs increases their 
pharmacokinetic properties in comparison to liposomal free drugs. 
 
d) Torchilin V.P- Recent advances with liposomes as pharmaceutical carriers  
Liposomes have been in recent demand due to their potential as great pharmaceutical carriers. 
There have recent developments of drug encapsulation process in liposomes; liposomes are 
also being used for gene delivery. For further success in development of this field, promising 
trends should be identified and exploited.  
 
e) Seema Sood, 1999- Characterization of liposome manufacturing using extrusion 
The process parameters of extrusion where changed to study the effect on liposome and its 
properties. The size characterisation was done by Dynamic Light Scattering, Capillary 
Hydrodynamic and Zimm Plots. Extrusion history did not affect mean size but it did affect 
mean size. 
 
f) Martin Francis et.al, 1998-The challenge of liposomes in gene therapy  
Recently, liposomes are also being used as gene delivery systems: most methods use 
intratumoral, subcutaneous and other local delivery. Stealth liposomes (coated with 
polyethylene glycol to camouflage the liposome and evade detection by the immune system) 
have a remarkable longevity in body fluids, have negligible toxicity with respect to their lipid 
components, reduce the toxicity of the encapsulated drug, and can deliver efficiently their 
doxorubicin payload (DOXIL) or cis-platin to definite targets. This paper proposes that these 
stealth liposomes, could find future applications to deliver plasmid DNA with therapeutic 
genes. 
 
g) Beroard J.C et.al-  A note on sugar determination by anthrone method 
Anthrone is used a cellular assay for colorimetric determination of carbohydrate. It reacts 
with the carbohydrate to produce a purple pink complex. The rated and extent of colour 
development with anthrone test differs with different sugar having similar structure. Anthrone 
has an advantage over phenol and orcinol procedure because it is applicable to 80% of 
ethanol extracts and even reacts with fructose at 50 degree centigrade. 
  
h) Satpathy G.R et. al,2004-Loading red blood cells with trehalose: a step towards 
biostabilization . 
High viability of RBCs preservation is of utmost importance for blood transfusion and 
clinical medicine.  Trehalose, a well known disachharide, which can survive dehydration, can 
help in RBC’s preservation. Trehalose is can be loaded onto RBCs by the phospholipid phase 
transition and osmotic imbalance, resulting in intracellular trehalose concentrations of about 
40 mM. Trehalose acts as cryoprotectants, increasing osmotic protection of RBCs. 
 
i) Holovati J.L et.al,2008-Effects of trehalose-loaded liposomes on red blood cell 
response to freezing and post-thaw membrane quality  
Liposomes are being tested for intracellular delivery of trehalose to mammalian cells. 
Liposome-treated RBCs  were resuspended in either physiological saline, 0.3 M trehalose or 
liposome solution, then cooled with slow, medium and fast cooling rates and storage in liquid 
nitrogen, followed by a 37 degree C thawing step. The cell viability test a postthawing shows 
that the recovery of RBCs frozen in liposome solution and trehalose solution was 
significantly higher than that of RBCs frozen in NaCl solution. 
 
j) Farrugia A. et. al,1993-Cryopreservation of red blood cells: effect of freezing on red 
cell quality and residual lymphocyte immunogenicity 
This paper investigates treatment with glycerol/washing as a potential substitute for freeze-
thawing in the production of leucocyte. The standard procedure of treatment with glycerol, 
freezing, thawing, washing was compared with a similar procedure in which freezing was 
omitted. Compared with red cells subjected to the standard freeze-thaw technique, red cells 
undergoing the non-freezing procedure and suspended in additive solutions had significantly 
better biochemical preservation. 
 
k) Lopez M. F. et. al 1984-  Levels of trehalose and glycogen in Frankia sp. HFPArI3 
(Actinomycetales) 
The levels of soluble trehalose were compared in Frankia sp. Ar13 under various conditions 
in batch culture. Levels reach a peak of 10-20% cell dry weight depending on cultural 
conditions, then drop to a minimum of 1-2% cell dry weight. A similar pattern is observed 
whether cells are grown in a medium containing NH4CL or in a medium lacking nitrogen 
substrates; however, the total levels of trehalose are higher in the latter. When cells were 
inoculated into a medium lacking nitrogen to induce fixation of atmospheric nitrogen, 
trehalose levels reached their peak in 4 day after which the level dropped. 
 
l) Quan G. et. al. 2007- Intracellular sugars improve survival of human red blood cells 
cryopreserved at -80 degrees C in the presence of polyvinyl pyrrolidone and human 
serum albumin 
This study focuses on the effect of intracellular trehalose or glucose on human red blood cells 
cryopreserved in the presence of a polymer. Red blood cells were cryopreserved for 48 h-72 h 
at -80 degrees C. The percent hemolysis induced by intracellular trehalose was less than that 
induced by extracellular trehalose, but the difference was not significant. Cryopreservation 
can increase the percentage of cells with exposed phosphatidylserine (PS), but the ability of 
trehalose to maintain PS normal distribution is higher than that of glucose. Furthermore, 
intracellular sugars can protect membrane integrity of cryopreserved red blood cells, although 
a small portion of cells appeared spherocytic or echinocytic shape. 
 
m) Chen Y. et. al.- 2006- Trehalose loading red blood cells and freeze-drying 
preservation 
This study was aimed to investigate the effect of trehalose on lyophilized RBCs. The RBCs 
were observed by light and scanning electron microscopy, the hemolysis rate of loaded RBCs 
was detected by using Drabkin’s kit, the intracellular trehalose levels were measured by 
anthrone method. The results showed that the intracellular trehalose concentration was 36.56 
+/- 7.95 mmol/L, the microscopic images of trehalose-loaded RBCs showed the membrane 
integrity, the hemolysis rate in trehalose-loaded RBCs was 15.663 +/- 3.848%, while 
hemolysis rate in controlled RBC was 5.03 +/- 1.85%. 
 
 
 
 
 
CHAPTER 3: MATERIALS AND METHODS 
 
3.1-Chemicals and Reagents used 
1. Lecithin-  HIMEDIA 
2. Cholesterol- HIMEDIA 
3. Chloroform-Rankem 
4. Methanol- Lobal chemie 
5. Trehalose - HIMEDIA 
6. Drabkin’s reagent –Crest biosystems 
7. Anthone- 
8. PBS 
 NaCl- HIMEDIA 
 KCl- Qualigen 
 Na2HPO4- Qualigen 
 K2HPO4- Lobal  
9. ADSOL solution 
 NaCl- HIMEDIA 
 Dextrose- Rankem 
 Adenine-  Lobal chemie 
 Mannitol- Lobal chemie 
10. CPDA solution 
 Trisodium citrate- SRL 
 Citric acid- Rankem 
 Dextrose- Rankem 
 Adenine-  Lobal chemie 
11. Blood collection by the adult donor of laboratory 
 
3.2-Apparatus and important Wearing 
Glass wares like measuring cylinder, beakers, small petri plates, test tubes flasks etc and 
plastic wares like syringe, falcon tubes, and eppendof tube. 
INSTRUMENT 
1. Bath sonicator- APE  
2. Microscope- Olympus iNEA 
3. Vortexer-  SPINIX 
4. Centrifuge 
5. Rotatory vacuum evaporator- IKA RV 10 
6. Controlled rate freezer- PLANER Kryo 560-16 
7. Spectrophotometer- SYSTRONICS Double Beam Spectrophotometer 2203 
8. Nano Zetasizer- NANO ZS 
9. Water bath- REMI  
10.  Micro centrifuge  
11.  Fourier Transform Infrared Spectroscopy- Perkin Elmer , SQ 300S 
3.3-Methods used  
 
1. Bath sonicator method of preparation of liposomes 
 A solution was made by adding 0.02g of cholesterol and 0.24g of lecithin to 3ml of n-
hexane, to this solution 12 ml PBS was added and was vortexed for 30-35 minutes. 
This solution was kept in water bath for 5 minutes at 40 degree Celsius. Another 
solution was produced by using the above procedure which was vortexed in a water 
bath for 8 minutes at 60 degree Celsius. 
 Three different solutions of oil and water were made. One solution has 20% (v/v) 
ATDL in water, another has 40% (v/v) and the other has 60 %(v/v).All tubes are 
vortexed for half an hour and centrifuged at 2000 rpm for 5 minutes. After 
centrifugation oil, water and tissue is separated. The separated water is sonicated in 
bath sonicator for 9mins at 40 degree Celsius. 
2.  Ether infusion method of preparation of liposomes 
A solution was made up of 2 ml ATDL and 3ml of diethyl ether. 80ml PBS was kept in a 100 
ml beaker in water bath at 60 degree Celsius (preheated). This was homogenized at 200 rpm 
and the solution was added to it 1 drop at a time. After the entire solution is added the 
homogenizer is kept on for about 10 minutes. 
3.  Lipid film hydration by rotatory vacuum evaporator method of preparation of liposomes. 
A solution is made of 6 ml chloroform and 3 ml methanol to which 0.72g of lecithin and 0.06 
of cholesterol is added. The solution is vortexed for 30-40 minutes till the lecithin and 
cholesterol is fully dissolved. This solution is added to round bottom flask of the rotatory 
vacuum evaporator. The temperature of the water bath attached to the rotatory vacuum 
evaporator is raised to 66 degree Celsius. The solution is rotated at 25 rpm till the all solvent 
gets evaporated and a thin lipid film is visible. 36 ml of PBS is added to the round bottom 
flask and the flask was vigorously vortexed till the entire film is dissolved in the aqueous 
medium. 
4. Folch method (Folch et al., J Biological Chemistry 1957, 226, 497) for the preparation of 
liposomes from adipose tissue 
The tissue is homogenized with chloroform/methanol in 2:1 ratio, to a final volume 20 times 
the volume of the tissue sample .After dispersion, the whole mixture is allowed to stand for 5 
minute at room temperature after that the mixture is agitated for 15-20 min in an orbital 
shaker at room temperature. The mixture is either filtrated or centrifuged (again and again) to 
recover the liquid phase. The solvent is washed with 0.2 volumes (4 ml for 20 ml) of water or 
0.1ml HCl solution. After vortexing for some time, the mixture is centrifuged at 2000 rpmto 
separate the two phases. Upper phase is removed. After centrifugation and removing of the 
upper phase, the lower chloroform phase that contains lipids is evaporated under vacuum in a 
rotary evaporator. The temperature of the water bath attached to the rotatory vacuum 
evaporator is raised to 66 degree Celsius. The solution is rotated at 25 rpm till the all solvent 
gets evaporated and thin lipid film is visible. 36 ml of PBS is added to the round bottom flask 
and the flask is vigorously vortexed till the entire film is dissolved in the aqueous medium. 
5. Preparation of liposomes loaded with trehalose 
Two sets of liposome are prepared by the rotary vacuum evaporation method, one with 
lecithin cholesterol and the other with ATDL. These liposomes are loaded with trehalose 
buffer (300mM trehalose). The liposomes are concentrated by centrifuging at 3500 rpm for 
10 minutes and the supernatant is disposed. 
 
FIGURE 3.1: IKA rotatory vacuum evaporator RV 10 
6. Size characterisation of liposomes: 
A Zetasizer was used to measure particle and molecule size by Dynamic Light Scattering and 
to measure Zeta Potential. Dynamic Light Scattering is used to measure particle and molecule 
size. DLS measures the diffusion of particles moving under Brownian motion, and converts 
this to size and size distribution using the Stokes-Einstein relationship. 
7. Anthrone test for analysis of trehalose uptake by the liposomes 
PRINCIPAL- 
In this test carbohydrates are dehydrated by to form conc. H2SO4 to form furfural which in 
turn complexes with anthrone to form a bluish green complex which can be measured 
colorimetrically at 620 nm by using a spectrophotometer.  
PROCEDURE- 
 8 test tubes are obtained and labeled.  
 50µl of water is added to test tube 1 for reagent blank.  
 Trehalose standards 2, 4, 6, 8, 10 mg of pure trehalose in test tubes 2 to 6.  
  50µl of liposome made from lecithin cholesterol is added to test tube 7 
 50µl of liposome made from ATDL  is added to test tube 8 
 To each test tube 2.9ml of anthrone reagent is added which was prepared by adding 
0.2% anthrone in 100ml of conc. H2SO4  and vortexed for 30 seconds 
 Test tubes and removed and placed in cold water for 10 minutes 
 Absorbance is checked against blank at 620nm. 
8. Cryopreservation of RBCs with liposomes loaded with trehalose 
The blood is collected from healthy human adult volunteers (7 ml) in CPDA solution and 
stored at 4 degree Celsius for 1-4 hours. 0.5 ml of blood is added 6 different cryovials .Then 
to each test tube different solutions are added. 
Cryovial 1- whole blood (1ml) 
Cryovial 2- 0.5ml PBS 
Cryovial 3- 0.5ml liposome lecithin cholesterol 
Cryovial 4- 0.5ml liposome ATDL 
Cryovial 5- 0.5 ml liposome (lecithin) loaded with trehalose 
Cryovial 6- 0.5ml liposome (ATDL) loaded with trehalose 
All the cryovials are incubated at 4 degree Celsius for 1-4 hours. The samples are 
cryopreserved by a controlled rate freezer by freezing the sample from 0 degree Celsius to -
10 degree Celsius at 1degree/min and then from -10 degrees to -100 degree at 10 degree 
Celsius/min. 
After the cyrovials are cooled till -100 degree Celsius they are plunged into liquid nitrogen at 
-196 degree and stored there overnight. 
9. Percentage Hemolysis using Drabkin’s Reagent  
PRINCIPLE- 
Hemoglobin is converted to methemoglobine by potassium ferricynde in the sample. Then a 
complex cynamethmoglobin is formed when methenoglobin further reacts with potassium 
cyanide. The complex is very stable and denotes a peculiar color whose intensity is directly 
proportional to concentration of plasma hemoglobin. The actual happening in hemolysis is 
that the RBC gets broken and starts releasing hemoglobin. Therefore, we can measure 
hemolysis by measuring the concentration of hemoglobin in the cell suspension, after 
centrifuging all blood samples at 500 rpm by a microcentrifuge. Then we measure their 
absorbance at 540 nm of their supernatant.  
PROCEDURE- For hemoglobin assay 20µl of blood is added to 5ml of Drabkin's solution. 
The sample is incubated at room temperature for 5 -10 mins and the absorbance were taken at 
540 nm in a spectrophotometer. A calibration curve is first determined from hemoglobin 
standard that has 0.6mg/ml. The hemoglobin concentration in the samples is determined by 
the standard curve and the percentage hemolysis is determined by 
Percentage hemolysis = (OD540nm of sample)/ (OD540 nm of whole blood) * 100 
10. Fourier transform infrared spectroscopy (FTIR) of liposomes- the intensity of liposomes 
and liposomes loaded with trehalose is measured over a narrow range of wavelength at a time 
by FTIR machine (Perkin Elmer, SQ 300S). 
CHAPTER 4: RESULTS AND DISCUSSIONS 
 
4.1-Liposome 
 
FIGURE 4.1- Average size characterisation of the liposome prepared by Sonication 
 
 
FIGURE 4.2- Average size characterisation of the liposome (ATDL) prepared by Sonication 
 
The average size of liposomes made up of ATDL by sonication method is 284.4nm 
(diameter) and of the liposomes made up of lecithin is 772.8nm. The adipose tissue liposomes 
are smaller in size. 
 A:FIGURE 4.3- Liposome formed from ATDL by ether infusion method 
B:FIGURE 4.4- Liposome prepared by lecithin cholesterol by rotatory vacuum evaporator 
 
FIGURE 4.5- Average size characterisation of the liposome prepared by lecithin cholesterol by rotatory vacuum 
evaporator 
  
C-FIGURE 4.6- Liposome prepared by lecithin cholesterol by rotatory vacuum evaporator and sonicated for 
280s  
D-FIGURE 4.7- Average size characterisation of the liposome prepared by lecithin cholesterol by rotatory 
vacuum evaporator and sonicated for 280s 
A B 
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 E-FIGURE 4.8- Liposome prepared by ATDL by rotatory vacuum evaporator 
F-FIGURE 4.9- Average size characterisation of liposome prepared by ATDL by rotatory vacuum evaporator 
 
 
  
FIGURE 4.10- Liposome prepared by ATDL by rotatory vacuum evaporator and sonicated for 280 seconds 
FIGURE 4.11- Average size characterisation of liposome prepared by ATDL by rotatory vacuum evaporator 
and sonicated for 280 seconds 
 
The liposomes produced by rotatory vacuum evaporator are larger than the ones produced 
with sonication method, the average diameter of liposome from lecithin are larger (1100nm) 
in size than the liposomes from ATDL (474nm). The same trend is observed when the 
liposomes are sonicated for 280 seconds the average diameter of liposomes produced by 
average diameter of liposome from lecithin is 550nm and 265nm. 
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4.2-Anthrone test for percentage trehalose encapsulation 
 
Tube  Sample Content Anthrone Absorbance 
at 620nm 
1 Blank         2.9ml  
2 Standard (50µl) 2mg        2.9ml 0.049 
3 Standard (50µl) 4mg        2.9ml   0.145 
4 Standard (50µl) 6mg        2.9ml 0.125 
5 Standard (50µl) 8mg        2.9ml 0.381 
6 Standard (50µl) 10mg        2.9ml 0.424 
7 Liposome(lecithin) (50µl)        2.9ml 0.81 
8 Liposome (ATDL) (50µl)        2.9ml 0.32 
Table 2: Table for anthrone test 
 
FIGURE 4.12:  Standard graph of concentration of trehalose 
 
The concentration of the standard curve starts with 2mg/50microlitre till 20mg/50µl. The 
concentration for liposome (lecithin-cholesterol) came out as 18mg/50µl which is 60mg/1ml. 
The concentration for liposome (ADL) came out as 8mg/50µl which is 160mg/1ml. The 
amount of trehalose put in the buffer was 300mm which was 11.6g/1ml or 1160mg/1ml. So 
percentage trehalose encapsulated by liposome (lecithin-cholesterol) is 31.03% or and 
percentage trehalose encapsulated by liposome (ADL) is 13.79% 
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4.3-Drabkin’s test for percentage hemolysis 
 
A standard calibration curve is made by using haemoglobin standard. 
Stock solution 
(0.6mg/ml) 
Drabkin’s 
reagent 
Concentration Absorbance at 
540 nm 
0 4ml 0 (blank) 0.00 
4ml 0ml 0.6mg/ml 0.57 
3ml 1ml 0.45mg/ml 0.43 
2ml 2ml 0.3mg/ml 0.31 
1ml 2ml 0.15mg/ml 0.18 
Table 3: Table for Drabkin’s test 
 
 
 
FIGURE 4.13: Calibration graph for hemoglobin. 
FIGURE 4.14: Different color intensity shown by Drabkin’s reagent due the presence of hemoglobin. 
 
 
The percentage hemoglobin in the sample is calculated by measuring absorbance at 540nm 
with the help of spectrophotometer. The amount of hemoglobin in each sample in supernatant 
determines the amount of cell lysis that has occurred. The percentage of hemolysis is 
calculated for each sample. 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0 0.2 0.4 0.6 0.8 
A
b
so
rb
an
ce
 
concentartion of hemoglobin in mg/ml 
 FIGURE 4.15: Hemoglobin concentration in mg/ml after cryopreservation 
 
 
 
FIGURE 4.16: Percentage hemolysis of samples   
 
It can be inferred from the results that liposomes themselves have some cryoprotective 
properties and even when they are not loaded with cryoprotectants. The liposomes made of 
lecithin cholesterol loaded with trehalose has the highest % survival of RBCs followed by 
liposomes made of ATDL loaded with trehalose, liposomes made of lecithin and cholesterol 
and liposomes made of ATDL. 
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4.4 – Fourier Transform Infrared Spectroscopy of liposomes  
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Figure 4.17: Intensity vs. wavenumber graph of liposomes made of lecithin cholesterol and oil and liposomes 
loaded with trehalose made of lecithin cholesterol and ATDL 
 
LTO refers to liposome (ATDL) loaded with trehalose, LTLC refers to liposome (lecithin) 
loaded with trehalose while LO is liposome made of ATDL and LLC is liposome from 
lecithin –cholesterol. All the samples have peaks at 3011 and 1160 which denotes the 
presence of lecithin. All the samples also have peaks at 3399 and 1670 which denotes the 
presence of cholesterol. The first two samples also have peaks at also has peaks at 1041.46 
and 991.45 which point towards the presence of trehalose in those sample. The 3550 - 3200 
peaks denote Alcohol/Phenol O-H Stretch, Alkynyl C=C Stretch is because of peaks in the 
region 2260 - 2100 and Amide C=O Stretch is given by the 1690 – 1630 peaks. 
 
 
 
CHAPTER 5: CONCLUSION 
 
The adipose tissue derived lipids form liposomes in with the help of thin film hydration 
method. These liposomes are smaller in size than conventional liposomes. The uptake of 
trehalose, which is a water soluble drug, in case of liposomes made up of ATDL is less than 
the conventional liposomes. Liposomes, no matter what the source is have a cryoprotective 
effect on the RBC even when they are not loaded with any cryoprotectant. The 
conventionally produced liposomes loaded with trehalose have very high cryoprotective 
properties (viability-85% RBCs) but at the same time the cryoprotective properties of ATDL 
liposomes loaded with trehalose is also quite significant (viability-70% RBCs). The 
liposomes formed by adipose tissue derived lipids may have higher lipid content so 
encapsulation of lipid soluble drug or dye will be higher. Further tests leading to the 
encapsulation lipid soluble drugs in liposomes will bring out conclusive results. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6: REFERENCES 
 
a) Bangham,A.D., et.al,1964.-Negative staining of phospholipids and their structural 
modification by surface-active agents as observed in the electron microscope  
b) Bangham AD, et.al,1965-Diffusion of univalent ions across the lamellae of swollen 
phospholipids. 
c)  Beroard J.C et.al-  A note on sugar determination by anthrone method 
d)  Chen Y. et. al.- 2006- Trehalose loading red blood cells and freeze-drying 
preservation  
e) Farrugia A. et. al,1993-Cryopreservation of red blood cells: effect of freezing on red 
cell quality and residual lymphocyte immunogenicity 
f) Holovati J.L et.al,2008-Effects of trehalose-loaded liposomes on red blood cell 
response to freezing and post-thaw membrane quality 
g) http://www.authorstream.com/Presentation/vsnmurthy-331492-liposomes-ppt-
science-technology-powerpoint 
h) http://cmbi.bjmu.edu.cn/cmbidata/therapy/research/re02/005.htm 
i) http://www.chem.ucla.edu/~webspectra/irtable.html 
j) http://www2.chemie.unierlangen.de/services/dissonline/data/dissertation/Christoph_
Wabel/html/Chapter4.html  
k) http://www.malvern.com/labeng/products/zetasizer/zetasizer_nano/zetasizer_nano_zs
p.htm 
l) http://www.nanopharmaceuticals.org/Liposomes.html 
m) http://www.pnas.org/content/105/13/5093/F3.expansion.html 
n) Lopez M. F. et. al 1984-  Levels of trehalose and glycogen in Frankia sp. HFPArI3 
(Actinomycetales) 
o) Martin Francis et.al, 1998-The challenge of liposomes in gene therapy 
p) Oleg K. et.al.-2002-A comparative study of gallstones from children and adults using 
FTIR spectroscopy and fluorescence microscopy 
q)  Quan G. et. al. 2007- Intracellular sugars improve survival of human red blood cells 
cryopreserved at -80 degrees C in the presence of polyvinyl pyrrolidone and human 
serum albumin. 
r) Samad A. et.al, 2007-Liposomal drug delivery systems: an Update review 
s) Satpathy G.R et. al,2004-Loading red blood cells with trehalose: a step towards 
biostabilization . 
t) Seema Sood, 1999- Characterization of liposome manufacturing using extrusion 
u) Sharma, A, 1997- Liposomes in drug delivery: Progress and limitations. Int. J. Pharm 
v) Symon, Z. et al.1999-Selective delivery of doxorubicin to patients with breast 
carcinoma metastases by stealth liposomes. 
w) Torchilin V.P- Recent advances with liposomes as pharmaceutical carriers  
x) Uhumwangho MU et. al., 2005-Current trends in the production and biomedical 
application of liposomes: a review 
 
 
 
 
 
